GB Patent

GB2591396B — Pharmaceutical suspension for oral dosage

Assigned to Lm Mfg Ltd · Expires 2023-06-07 · 3y expired

What this patent protects

Patent listed against Cellcept.

Drugs covered by this patent

Cellcept (MYCOPHENOLATE MOFETIL) · Roche Palo

Patent Metadata

Patent number: GB2591396B
Jurisdiction: GB
Classification: —
Expires: 2023-06-07
Drug substance claim: No
Drug product claim: No
Assignee: Lm Mfg Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.